Back to Search Start Over

Auditing service delivery in glaucoma clinics using visual field records: a feasibility study.

Authors :
Kelly SR
Bryan SR
Sparrow JM
Crabb DP
Source :
BMJ open ophthalmology [BMJ Open Ophthalmol] 2019 Aug 15; Vol. 4 (1), pp. e000352. Date of Electronic Publication: 2019 Aug 15 (Print Publication: 2019).
Publication Year :
2019

Abstract

Objective: This study aimed to demonstrate that large-scale visual field (VF) data can be extracted from electronic medical records (EMRs) and to assess the feasibility of calculating metrics from these data that could be used to audit aspects of service delivery of glaucoma care.<br />Method and Analysis: Humphrey visual field analyser (HFA) data were extracted from Medisoft EMRs from five regionally different clinics in England in November 2015, resulting in 602 439 records from 73 994 people. Target patients were defined as people in glaucoma clinics with measurable and sustained VF loss in at least one eye (HFA mean deviation (MD) outside normal limits ≥2 VFs). Metrics for VF reliability, stage of VF loss at presentation, speed of MD loss, predicted loss of sight years (bilateral VF impairment) and frequency of VFs were calculated.<br />Results: One-third of people (34.8%) in the EMRs had measurable and repeatable VF loss and were subject to analyses (n=25 760 patients). Median (IQR) age and presenting MD in these patients were 71 (61, 78) years and -6 (-10, -4) dB, respectively. In 19 264 patients with >4 years follow-up, median (IQR) MD loss was -0.2 (-0.8, 0.3) dB/year and median (IQR) intervals between VF examinations was 11 (8, 16) months. Metrics predicting loss of sight years and reliability of examinations varied between centres (p<0.001).<br />Conclusion: This study illustrates the feasibility of assessing aspects of health service delivery in glaucoma clinics through analysis of VF databases. Proposed metrics could be useful for blindness prevention from glaucoma in secondary care centres.<br />Competing Interests: Competing interests: DPC reports speaker fees from Allergan, Bayer, Santen; unrestricted funding from Allergan, Roche, Santen; consultancy with Centervue—all outside the remit of the submitted work.

Details

Language :
English
ISSN :
2397-3269
Volume :
4
Issue :
1
Database :
MEDLINE
Journal :
BMJ open ophthalmology
Publication Type :
Academic Journal
Accession number :
31523719
Full Text :
https://doi.org/10.1136/bmjophth-2019-000352